NCT06226948

Brief Summary

In the framework of PhD research, the investigators will present a visualization of estimation of CVDs risk and the possibility of monitoring blood glucose levels in real-time. Based on the results, the investigators will assess the association of these with lifestyle change. The findings highlight the need for sufficiently reliable and high-quality evaluations of visualizations, technologies or applications used in the family medicine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable cardiovascular-diseases

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 26, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

May 6, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2024

Completed
Last Updated

January 24, 2025

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

January 17, 2024

Last Update Submit

January 21, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Assessment of change of lifestyle.

    Change of lifestyle will be assessed using the Healthy Lifestyle and Personal Control Questionnaire from Darviri, et al., 2014. The goal of this questionnaire is to detect and quantify lifestyle patterns that reflect health empowerment and for assessing the efficacy of future health-promoting interventions to improve individuals' lifestyles and wellbeing. The assessment is based on a 4-point Likert scale (1 = never or rarely, 2 = sometimes, 3 = often and 4 = always). The final calculation of lifestyle is based on the sum of the dimensions. The dimensions can also be compared individually with each other at the final stage to determine which dimension has experienced the greatest change in lifestyle. The minimum possible score is 31, indicating no change in lifestyle, and the maximum possible score is 90, indicating the greatest change in lifestyle.

    Change in Healthy Lifestyle and Personal Control Questionnaire score will be assessed at the enrolment of the participants followed by the examination in the period of up to 6 months after the enrolment.

  • Assessment of person-centred care.

    The Person-Centred Practice Inventory - Service User consists of 20 items measuring participants agreement with statements related to perceptions of person-centred care and includes 5 constructs: working with participants beliefs and values, shared decision making, compassionate presence and holistic care.The score is based on a 5-point Likert scale. The lowest level of participants agreement is 20 and the highest level is 100.

    The Person-Centred Practice Inventory - Service User score will be assessed at the enrolment of the participants followed by the examination in the period of up to 6 months after the enrolment.

  • Systematic Coronary Risk Evaluation 2 risk

    Systematic Coronary Risk Evaluation 2 is designed to calculate the risk of CVD according to the Systematic Coronary Risk Evaluation 2 prognostic model (ESC, 2022).The higher the percentage, the higher the risk.

    Change in Systematic Coronary Risk Evaluation 2 score will be assessed at the enrolment of the participants followed by the examination in the period of up to 6 months after the enrolment.

Secondary Outcomes (1)

  • Assessment in Biological age

    Change in Biological age will be assessed at the enrolment of the participants followed by the examination in the period of up to 3 and 6 months after the enrolment.

Study Arms (4)

Intervention group 1

EXPERIMENTAL

Participants will use a continuous blood glucose monitoring and visualization of CVDs risk.

Device: CGMDiagnostic Test: Visualization

Intervention group 2

EXPERIMENTAL

Participants will use a continuous blood glucose monitoring.

Device: CGM

Intervention group 3

EXPERIMENTAL

Participants will use a visualization of CVDs risk.

Diagnostic Test: Visualization

Control group

NO INTERVENTION

No intervention.

Interventions

CGMDEVICE

Participants will wear CGM monitors for 10 days.

Also known as: Intervention 1, Intervention 2
Intervention group 1Intervention group 2
VisualizationDIAGNOSTIC_TEST

Enriched visualization of SCORE2 CVD risk.

Also known as: Intervention 1, Intervention 3
Intervention group 1Intervention group 3

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • individuals ages more than 40 years
  • without serious disease progression
  • at least one risk factor for CVDs

You may not qualify if:

  • individuals younger than 40 years
  • with serious disease progression
  • without risk factor for CVDs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Health Sciences

Maribor, Slovenia

Location

Related Publications (1)

  • Darviri C, Alexopoulos EC, Artemiadis AK, Tigani X, Kraniotou C, Darvyri P, Chrousos GP. The Healthy Lifestyle and Personal Control Questionnaire (HLPCQ): a novel tool for assessing self-empowerment through a constellation of daily activities. BMC Public Health. 2014 Sep 24;14:995. doi: 10.1186/1471-2458-14-995.

    PMID: 25253039BACKGROUND

Related Links

MeSH Terms

Conditions

Cardiovascular DiseasesCoronary Artery DiseaseHeart DiseasesCoronary Disease

Condition Hierarchy (Ancestors)

Myocardial IschemiaArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 17, 2024

First Posted

January 26, 2024

Study Start

May 6, 2024

Primary Completion

December 6, 2024

Study Completion

December 6, 2024

Last Updated

January 24, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

The anonymity of all research participants will be guaranteed throughout the research. Only the researcher involved will have access to the anonymised data.

Locations